C3 awards grant to University of Florida researchers to investigate calcium handling in LGMD2A/R1
Coalition to Cure Calpain 3 (C3) is driving LGMD2A/R1 research by awarding a new grant to Dr. Elisabeth Barton and Dr. Lan Wei-LaPierre of the University of Florida. The project is titled “Strategies to improve calcium handling in LGMD2A/R1.”
LGMD2A/R1 is caused by mutations in the gene for Calpain 3. Researchers do not fully understand the role of Calpain 3 in keeping muscle healthy. Experiments in animal models show one of the consequences of loss of Calpain 3 function is a failure of muscles to adapt to increased exercise. This study aims to clarify how calcium signaling, which is a key regulator of exercise response, is affected when Calpain 3 is absent. Further, Drs. Barton and Wei-LaPierre will use a mouse model of LGMD2A/R1 to test therapeutic strategies that normalize calcium handling in muscle.
“There is intriguing data that demonstrate Calpain 3 is important for muscle to adapt to increased exercise, and that this failure to adapt is central to LGMD2A/R1 pathogenesis. This exciting project will help us understand if targeting this pathway through altered calcium handling could be a potential treatment for LGMD2A/R1.” — Jennifer Levy, Scientific Director, Coalition to Cure Calpain 3
“We hope to synergize our collective expertise on calcium handling, muscle function, and signaling pathways to determine if there is a strategy that can enhance adaptation to exercise in LGMD2A/R1 to improve muscle strength without compromising existing functional capacity.” — Drs. Barton and Wei-LaPierre
Advancing Excellence in LGMD Diagnosis, Care, and Emerging Therapies (CME Accreditation) 📅 13-14 November 2026 | 📍 Atlanta, Georgia As new therapies move closer to clinical practice, the need for accurate diagnosis, specialist knowledge, and coordinated multidisciplinary care has never been greater. Developed for healthcare professionals involved in the diagnosis and management of limb-girdle muscular... Read More
A new paper, “CaMKIIβ Signaling drives expression of metabolic and stress response genes in skeletal muscle, and its loss contributes to the LGMDR1 phenotype,” was recently published in the journal Human Molecular Genetics. It was authored by a multi-institutional group led by Dr. Melissa Spencer, C3 Scientific Advisory Board Chair and Professor of Neurology and... Read More
